Galapagos

Galapagos is a global biotechnology company headquartered in Mechelen, Belgium, focused on discovering and developing life-changing medicines for patients. Their mission is to accelerate transformational innovation through relentless pursuit of groundbreaking science, entrepreneurial spirit, and a collaborative mindset. They are committed to bringing new therapies to patients faster, with a focus on high unmet medical needs in the areas of immunology and oncology.

Galapagos prioritizes patient care and well-being, actively engaging with patients and patient organizations throughout the medicine development process. They are also dedicated to acting as a responsible and sustainable business, striving towards environmental sustainability and building a culture of integrity, diversity, and inclusion within the company.

Galapagos offers a flexible work environment, empowering employees to manage their work schedule to achieve the best results. The company provides opportunities for learning and growth, recognizing contributions and rewarding sustained performance. It has also enhanced employee benefits, including increased pay for performance, broad-based equity awards, family leave, and mobility programs to encourage sustainable transportation.

Galapagos offers competitive remuneration packages that include performance bonuses and equity-related opportunities for many employees. The company provides a range of employee benefits that vary from country to country based on local customs and statutory conditions. These benefits have been enhanced internationally and locally, including increased pay-for-performance linkages in compensation reviews, broad-based annual equity awards, expanded family leave policies, improved time off and enhanced medical coverage, and mobility programs to encourage environmentally friendly transportation behavior.

Galapagos is a global biotechnology company dedicated to transforming patient outcomes through life-changing science and innovation, aiming to provide patients with more years of life and quality of life. They are driven by a mission to accelerate transformational innovation through relentless pursuit of groundbreaking science, an entrepreneurial spirit, and a collaborative mindset. Galapagos' efforts focus on high unmet medical needs, particularly in the areas of immunology and oncology, where they leverage their expertise in small molecules, CAR-T therapies, and biologics to deliver best-in-class medicines.

Galapagos promotes a culture focused on collaboration, innovation, and patient-centricity. The company emphasizes transparency, accountability, and ethical leadership in all aspects of its operations. Employees are encouraged to take ownership, learn and grow, and contribute to the company's mission of accelerating transformational innovation through groundbreaking science. This culture is further enhanced by Galapagos' commitment to diversity, equity, and inclusion, creating a welcoming and supportive environment for all employees.

Galapagos values and measures equity, transparency, diversity, and leadership quality to foster trust and belonging within the company. They conduct annual equity checks as part of their promotion and end-of-year review processes and strive for a balanced pipeline of future employees to maintain a healthy mix of talent at all levels of the organization. Galapagos aims to define a roadmap to achieve their goal of being a more diverse, equitable and inclusive organization by 2028 and to embed these values in everything they do, including their commitment to patients and strengthening their initiative to ensure that their clinical trials are designed with diversity as a key factor.